reports
Moody's Ratings affirms World Acceptance's B3 unsecured rating; change...
Moody's Ratings (Moody's) has affirmed World Acceptance Corporation's (WRLD) B2 corporate family rating (CFR) and B3 senior unsecured rating. Moody's changed the company's outlook to stable from negative. RATINGS RATIONALE The change in outlook to stable reflects the company's improved asset qua...
Ring Energy Announces Timing of First Quarter 2024 Earnings Release an...
Ring Energy Announces Timing of First Quarter 2024 Earnings Release and Conference Call THE WOODLANDS, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced the timing of its first quarter 2024 earnings release and conference call. Ring plans to issue its first quarter 2024 earnings release after the close of trading on Monday, May 6, 2024. The Company has scheduled a conference call on Tuesday, May 7, 2024 at 11:00 a.m. ET to discuss its first quarter 2024 operational and financial results. To participate, interested p...
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financi...
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Topline results from Phase 1b study of LTI-03, a novel Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis, expected to be reported in the third quarter of 2024 Cash runway expected to fund operations and key milestones into the fourth quarter of 2024 AUSTIN, Texas, April 15, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”, the “Company”, “we”, “our” or “us”) (NASDAQ: ALRN), a biopharmaceutical company advancing a ...
- Jeff Robertson
Scaling Business Through Acquisitions & Development
Acquisitions are expected to remain a centerpiece of management’s three-pronged strategy to increase scale in the asset base, reduce outstanding debt, and ultimately position the company to return cash to shareholders. The Stronghold acquisition in 3Q22, followed by the Founders acquisition in 3Q23, added operational scale and inventory depth on the southern portion of the Central Basin Platform (CBP). Together with Ring’s Northwest Shelf (NWS) assets, the inventory provides a diverse set of hor...
Ring Energy Announces Participation in Water Tower Research Fireside C...
Ring Energy Announces Participation in Water Tower Research Fireside Chat Event on March 26, 2024 THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced its participation in an investor event hosted by Water Tower Research (“WTR”) on March 26, 2024 at 2:00 PM Eastern. As part of WTR’s ongoing Fireside Chat Series, Jeff Robertson, Managing Director at WTR, will lead an in-depth conversation with Paul McKinney, Ring’s Chairman and Chief Executive Officer. Included in the discussion will be a variety of impor...
Homology Medicines Declares Distribution to Common Stockholders
Homology Medicines Declares Distribution to Common Stockholders BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of record as of the close of business on March 21, 2024 of the right to receive one contingent value right (CVR) for each outstanding share of Homology common stock held by such stockholder as of such record date. The payment date for such distribution is expected to be March 27, 2024 (three business days after the expected closing of the merger on March 22, 2024...
Ring Energy Announces Participation in 36th Annual Roth Conference
Ring Energy Announces Participation in 36th Annual Roth Conference THE WOODLANDS, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that the Company is scheduled to participate in the 36th Annual Roth Conference to be held in Dana Point, California from March 17-19, 2024. Paul McKinney, Chairman and Chief Executive Officer, Alex Dyes, Executive Vice President of Engineering and Corporate Strategy, and Travis Thomas, Executive Vice President and Chief Financial Officer will participate in the Conference and host one-...
Aileron Therapeutics Announces CEO Transition
Aileron Therapeutics Announces CEO Transition Current President and Chief Operating Officer, Brian Windsor, Ph.D., appointed Chief Executive Officer Dr. Windsor to lead Aileron into a new era focused on advancing a pipeline of first-in-class medicines for orphan pulmonary and fibrosis diseases WALTHAM, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced tha...
Ring Energy Announces Record Fourth Quarter and Full Year 2023 Results...
Ring Energy Announces Record Fourth Quarter and Full Year 2023 Results, Year-End 2023 Proved Reserves and Additional 2024 Guidance THE WOODLANDS, Texas, March 07, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported record operational and financial results for the fourth quarter and full year 2023, year-end 2023 proved reserves and provided additional 2024 operational and financial guidance. 2023 Q4 and Full Year Highlights and Recent Key Items Grew fourth quarter total sales volumes 11% to a record 19,397 barrels of oil equivalent...
Ring Energy Announces Timing of Fourth Quarter and Full Year 2023 Earn...
Ring Energy Announces Timing of Fourth Quarter and Full Year 2023 Earnings Release and Conference Call THE WOODLANDS, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced the timing of its fourth quarter 2023 earnings release and conference call. Ring plans to issue its fourth quarter and full year 2023 earnings release after the close of trading on Thursday, March 7, 2024. The Company has scheduled a conference call on Friday, March 8, 2024 at 11:00 a.m. ET to discuss its fourth quarter and full year 2023 operational...
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potenti...
Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event Topline results from Phase 1b study of LTI-03, Aileron’s novel Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis, expected in the second quarter of 2024 WALTHAM, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs ...
- Jeff Robertson
Estimate Update
Ring’s 4Q23 production averaged ~19,400 BOE/d, near the high end of management’s 18,900-19,500 BOE/d guidance range. Average production increased 11% from 3Q23, reflecting the full-quarter inclusion of volumes acquired in the Founders acquisition, which closed in August 2023, and from volumes added from the completion of the 2023 development program in the quarter. Management expects 1Q24 production to average 18,000-18,500 BOE/d. 1Q24 volumes were adversely affected by winter weather disruption...
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, ...
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024 Panel discussion will highlight LTI-03, Aileron’s novel Caveolin-1-related peptide, for the treatment of idiopathic pulmonary fibrosis WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that it will host a virtual key opinion leader event titled, “Clinical Perspectives on Tre...
Ring Energy Announces Production Results and Continued Debt Reduction ...
Ring Energy Announces Production Results and Continued Debt Reduction for Fourth Quarter 2023 and Partial Guidance for the First Quarter 2024 ~ Record Q4 2023 Sales Volumes Near High End of Guidance ~ ~ Further Reduced Debt in Addition to Making Final Payment for the Founders Acquisition ~ THE WOODLANDS, Texas, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today provided an operational and financial update for the fourth quarter of 2023, as well as production and capital spending guidance for the first quarter of 2024. Key High...
Ring Energy to Present at the Microcap Conference
Ring Energy to Present at the Microcap Conference THE WOODLANDS, Texas, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that Paul D. McKinney, Chairman and Chief Executive Officer, will present and host one-on-one meetings with investors during the Microcap Conference on January 31 - February 1, 2024 in Atlantic City, New Jersey. An updated investor deck prepared in conjunction with the conference will be available on Ring’s web site, , on January 31 in the “Investors” section of the site. About Ring Energy, Inc. Ring E...
Moody's affirms Golub Capital BDC, Inc.'s Baa3 senior unsecured debt r...
Moody's Investors Service (Moody's) has today affirmed Golub Capital BDC, Inc.'s (GBDC or Golub Capital) Baa3 long-term issuer and senior unsecured debt ratings following the company's announcement that it plans to merge with Golub Capital BDC 3, Inc. (GBDC3). GBDC's outlook was maintained positive....
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid ...
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement BEDFORD, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it received notification (“Nasdaq Notification”) from The Nasdaq Stock Market LLC (“Nasdaq”) on December 29, 2023 indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per ...
Ring Energy Announces Issuance of 2023 Sustainability Report
Ring Energy Announces Issuance of 2023 Sustainability Report THE WOODLANDS, Texas, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that it has issued its 2023 Sustainability Report (the “2023 Report”), which is available on the Company’s website at under the “Sustainability” tab. The report provides updated and comprehensive information about Ring’s Environmental, Social and Governance (“ESG”) initiatives and related key performance indicators. In the creation of the document, the Company primarily consulted the Sustai...
Ring Energy Announces Successful Results of Senior Credit Facility Fal...
Ring Energy Announces Successful Results of Senior Credit Facility Fall 2023 Redetermination and Final Payment for Founders Property Acquisition THE WOODLANDS, Texas, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that the borrowing base was reaffirmed at $600 million under its $1.0 billion senior revolving credit facility (the “Credit Facility”). In addition, the Company announced that it had recently made the final payment of $11.9 million on its previously-announced acquisition of the Central Basin Platform assets of F...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.